Ilika plc Commercialisation is in the ascendency

Ilika Plc
[shareaholic app="share_buttons" id_name="post_below_content"]

Ilika Plc (LON:IKA) is the topic of conversation when we caught up with Liberum Equity Research Analyst, Sam Wahab. We asked Sam:

What were the key points investors should be aware of?

First deliveries to Blink Energy and now to CubeWorks and Lura Health suggests commercialisation of Ilika’s medical SSBs is in the ascendency. Ongoing discussions with Cirtec remain encouraging with regards to Stereax outsourcing to the US and we would not be surprised to see a positive near-term outcome. At Goliath, the company is targeting Li-ion energy density parity by the end of 2023(currently >80%) ahead of implementing a scale-up to mega-factory scale in order to support a commercial roll-out of a small portfolio of electric hyper and super car models. Ilika’s share price (albeit +100% YTD) continues to reflect material value to investors in our view.

Have you adjusted your forecasts in any way?

No change as yet, but once details of existing shipments are made public (i.e quantity, ASP etc) and discussions conclude with Cirtec – we will revisit.

How do you see the company in terms of fair value?

Currently we model Stereax on a FY25E 20x multiple on 30,000 units sold which is very conservative given recent events. Goliath is on 20x 2040E EV/EBITDA. Overall 60p/share TP ahead of details outlined above – scope to revisit once we have more information on shipments/discussions etc.

Ilika is a pioneer in solid state battery technology, enabling solutions for applications such as Industrial IoT, MedTech, EV and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Ilika wins £1.25m APC grant for Goliath A-Samples (LON:IKA)

Ilika has secured £1.25m from the Advanced Propulsion Centre’s Demonstrate fund within the Government’s new £2.5bn Drive35 programme, supporting a £3m, 12-month PRIMED project with HSSMI and UKBIC to produce Goliath A-Samples.

Digital replication shapes Ilika’s path to mass market solid state cells

Ilika is blending virtual factory modelling with physical cell production to de-risk and accelerate the scale-up of its Goliath solid state batteries for automotive licensing.

Ilika plc: Goliath Milestones and Medtech Momentum Fuel Investor Optimism (Video)

Baden Hill’s Clean-Tech Equity Specialist Dr Tom McColm outlines why investors should pay attention to 2025 as the year Ilika shifts gears

Ilika Plc Goliath Milestones and First Revenues with CEO Graeme Purdy (Video)

Graeme Purdy reveals how the company’s Goliath solid-state batteries, designed for electric vehicles, are now validated by OEM partners and on the cusp of generating commercial revenue.

Ilika FY25 results: Stereax manufacturing shift, Goliath roadmap

Ilika reported results for the year ended 30 April 2025. The group advanced transfer of Stereax miniature solid state battery manufacturing to Cirtec in the US and validated Goliath EV prototypes, including scale up work at UKBIC.

Ilika plc £1.25M Grant Powers Goliath Battery Leap in UK’s EV Race, Graeme Purdy Explains (Video)

Graeme Purdy outlines how Ilika is positioning itself to license, not manufacture, at gigafactory scale. Investors watching the solid-state battery space will want to know what’s coming next, and when.

Search

Search